Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001931266 | SCV002201897 | uncertain significance | Familial aplasia of the vermis | 2022-11-22 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glutamic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 1426382). This variant has not been reported in the literature in individuals affected with AHI1-related conditions. This variant is present in population databases (rs763715513, gnomAD 0.04%). This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 13 of the AHI1 protein (p.Lys13Glu). |
Gene |
RCV004762257 | SCV005369149 | uncertain significance | not provided | 2023-06-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV005042535 | SCV005668548 | uncertain significance | Joubert syndrome 3 | 2024-06-14 | criteria provided, single submitter | clinical testing |